UPDATE: Rosetta Genomics (ROSG) Ramps On New Buy Rating; Analyst Sees 238% Upside
Go back to UPDATE: Rosetta Genomics (ROSG) Ramps On New Buy Rating; Analyst Sees 238% UpsideGenomic Health, Inc. (NASDAQ: GHDX) | Delayed: 63.44 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $63.44 | 52 Week High | $35.79 | |||
Open | $12.85 | 52 Week Low | $22.00 | |||
Day High | $63.44 | P/E | N/A | |||
Day Low | $63.44 | EPS | $-0.42 | |||
Volume | 32,882 |
ROSETTA GENOMICS (NASDAQ: ROSG) | Delayed: 0.43 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.43 | 52 Week High | $1.84 | |||
Open | $0.02 | 52 Week Low | $0.55 | |||
Day High | $0.43 | P/E | N/A | |||
Day Low | $0.43 | EPS | $0.00 | |||
Volume | 1,347 |